Anxiety, Depression in Adolescence, Loneliness, Social Connectedness
Conditions
Brief summary
The goal of this clinical trial is to learn if a personalized arts-based social prescribing program, Art Pharmacy, delivered through a mobile app (SocialRx App) can improve mental health and social connectedness in adolescents aged 15-18 with depression or anxiety enrolled in Medicaid managed care. The main question it aims to answer is: Compared to stable treatment, does participation in the Art Pharmacy program through the SocialRx App improve depression, anxiety, social connectedness, and loneliness? Researchers will compare participants receiving the Art Pharmacy program and digital companion to those receiving stable treatment (no change to existing care) to evaluate its effects on mental health and social connectedness. Participants will: Be randomly assigned to either the Art Pharmacy program delivered through the SocialRx App or a control group receiving stable treatment. Complete online surveys at baseline and follow-up time points (e.g., 3, 6, 9, and 12 months). If assigned to the intervention group, Art Pharmacy, participants will receive monthly arts and cultural activity recommendations, attend activities, and interact with a care navigator delivered through the SocialRx App.
Interventions
A personalized arts-based social prescribing program
Stable treatment (no change to existing care) through Medicaid managed care
Sponsors
Study design
Eligibility
Inclusion criteria
Participants must meet the following criteria: * Aged 15-18 years enrolled in Medicaid managed care * Positive screen for depression and/or anxiety (e.g., PHQ-2 or GAD-2 ≥ 3) * Currently own and easily operate a smartphone * Have a valid e-mail address checked regularly * English fluency, and * Have a stable treatment regimen for at least 30 days prior to baseline with no planned treatment changes.
Exclusion criteria
Participants will be excluded if they: * Endorse current suicidal ideation at study screening, defined as a response ≥ 1 ("several days") on Item 9 of the PHQ-9A * Initiate a new treatment regimen or plan on initiating a new treatment regimen (i.e., medication, psychotherapy, or mind-body interventions) at the time of enrollment.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Anxiety - Generalized Anxiety Disorder-7 (GAD-7) | At baseline, and 3-, 6-, 9- and 12-month follow up. | The GAD-7 is a 7-item self-report measure of anxiety symptoms. Scores range from 0 to 21, with higher scores indicating greater anxiety severity. |
| Depression - Patient Health Questionnaire-9 Adolescent Version (PHQ-9A) | At baseline, and 3-, 6-, 9- and 12-month follow up. | The PHQ-9A is a 9-item self-report measure of depressive symptoms in adolescents. Scores range from 0 to 27, with higher scores indicating greater depression severity. |
| Loneliness - UCLA Loneliness Scale | At baseline, and 3-, 6-, 9-, and 12-month follow up | The UCLA Loneliness Scale assesses subjective feelings of loneliness and social isolation. Scores range from 20 - 80, with higher scores indicating a higher degree of loneliness. |
| Social Connectedness - Social Connectedness Scale-Revised (SCS-R) | At baseline, and 3-, 6-, 9-, and 12-month follow up | The SCS-R measures feelings of interpersonal closeness and connectedness. Scores range from 20 to 120, with higher scores indicating greater social connectedness. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Treatment Utilization - Treatment and Arts/Cultural Engagement Utilization Questionnaire | At baseline, and 3-, 6-, 9-, and 12-month follow up | A study-developed questionnaire assessing participant engagement with behavioral health treatment and arts/cultural activities. Higher scores/frequencies indicate greater utilization and engagement. |
Contacts
SocialRx Inc